Trial Drugs for Huntington's Disease Inconclusive in Slowing DiseaseMonday, Aug 13, 2001
A large-scale clinical trial that tested the ability of the investigational drugs remacemide and Coenzyme Q10 to slow the
progression of Huntington's disease showed that neither drug resulted in any significant improvement for the patients. Although
after one year of treatment, the disease seemed to progress more slowly in patients treated with Coenzyme Q10, the investigators
say that overall the results are inconclusive as to whether there is real benefit from this drug.
Fact Sheet Scientists Identify Gene for Spinocerebellar Ataxia 2Thursday, Oct 31, 1996
Scientists have identified the gene altered in one of the most common hereditary ataxias, spinocerebellar ataxia 2 (SCA2).
The discovery allows improved genetic testing and provides new clues about how genetic mutations cause several neurological
disorders, including Huntington's disease. The findings are reported by three different groups in the November issue of Nature
Genetics.